Role of substance P in hypersensitivity reactions induced by paclitaxel, an anticancer agent

Peptides

Volumn 25, Issue 7, 2004, Pages 1205-1208

  Sendo, Toshiaki ^a   Itoh, Yoshinori ^a   Goromaru, Takeshi ^a   Hirakawa, Toshio ^b   Ishida, Mawako ^a   Nakano, Hitoo ^b   Oishi, Ryozo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Acute lung injury; Histamine; Hypersensitivity; NK1 antagonist; Paclitaxel; Plasma extravasation; Substance P

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; DEXAMETHASONE; HISTAMINE; LANEPITANT; PACLITAXEL; SUBSTANCE P;

ANIMAL EXPERIMENT; ARTERIAL OXYGEN TENSION; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG HYPERSENSITIVITY; EXTRAVASATION; FEMALE; HISTAMINE BLOOD LEVEL; HUMAN; LUNG EDEMA; LUNG LAVAGE; MALE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HISTAMINE; HUMANS; HYPERSENSITIVITY; INDOLES; MALE; OVARIAN NEOPLASMS; PACLITAXEL; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; SUBSTANCE P;

EID: 3042733290     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.04.004     Document Type: Article

References (12)

1. 1 receptor antagonists in the anaesthetized rat. Eur. J. Pharmacol. 18:1996;377-385
2. Cormio G., Di Vagno G., Melilli G.A., Cazzolla A., Di Gesu G., Carriero C., et al. Hypersensitivity reactions in ovarian cancer patients receiving paclitaxel. J. Chemother. 11:1999;407-409
3. Frode-Saleh T.S., Calixto J.B., Medeiros Y.S. Analysis of the inflammatory response induced by substance P in the mouse pleural cavity. Peptides. 20:1999;259-265
4. Itoh Y., Oishi R., Adachi N., Saeki K. A highly sensitive assay for histamine using ion-pair HPLC coupled with postcolumn fluorescent derivatization: its application to biological specimens. J. Neurochem. 58:1992;884-889
5. Itoh Y., Sendo T., Hirakawa T., Goromaru T., Takasaki S., Yahata H., et al. Role of sensory nerve peptides rather than mast cell histamine in paclitaxel hypersensitivity. Am J Respir Crit Care Med. 169:2004;113-119
6. Kris M.G., O'Connell J.P., Gralla R.J., Wertheim M.S., Parente R.M., Schiff P.B., et al. Phase I trial of taxol given as a 3-hour infusion every 21 days. Cancer Treat Rep. 70:1986;605-607
7. Krishna M.T., Springall D.R., Meng Q.H., Whiters N., Macleod D., Biscione G., et al. Effects of ozone on epithelium and sensory nerves in the bronchial mucosa of healthy humans. Am. J. Respir. Crit. Care Med. 156:1997;943-950
8. Kwon J.S., Elit L., Finn M., Hirte H., Mazurka J., Moens F., et al. A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel. Gynecol. Oncol. 84:2002;420-425
9. Markman M., Kennedy A., Webster K., Peterson G., Kulp B., Belinson J. An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions. J. Cancer Res. Clin. Oncol. 125:1999;427-429
10. Mashito Y., Ichinose M., Sugiura H., Miura M., Endoh N., Shirato K. Sensory nerve activation in airway microvascular permeability in guinea-pig late allergic response. Eur. Respir. J. 14:1999;320-327
11. McDonald D.M., Mitchell R.A., Gabella G., Haskell A. Neurogenic inflammation in the rat trachea. II. Identity and distribution of nerves mediating the increase in vascular permeability. J. Neurocytol. 17:1988;605-608
12. Van Rensen E.L., Hiemstra P.S., Rabe K.F., Sterk P.J. Assessment of microvascular leakage via sputum induction: the role of substance P and neurokinin A in patients with asthma. Am. J. Respir. Crit. Care. Med. 165:2002;1275-1279